Filing Details
- Accession Number:
- 0001104659-20-030294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-06 18:16:43
- Reporting Period:
- 2019-07-31
- Accepted Time:
- 2020-03-06 18:16:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609550 | Inspire Medical Systems Inc. | INSP | Surgical & Medical Instruments & Apparatus (3841) | 261377674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1737127 | Randy Ban | C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-04 | 10,000 | $1.14 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-04 | 1,801 | $84.33 | 8,199 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-04 | 1,673 | $85.19 | 6,526 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-04 | 1,613 | $86.38 | 4,913 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-04 | 1,730 | $87.40 | 3,183 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-04 | 3,044 | $88.09 | 139 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-04 | 139 | $89.10 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-07-31 | 25,000 | $0.00 | 25,000 | $67.63 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-04 | 10,000 | $0.00 | 10,000 | $1.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2029-07-31 | No | 4 | A | Direct | |
| 55,187 | 2023-09-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 167 | Indirect | By son |
| Common Stock | 166 | Indirect | By daughter |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.88 to $84.77. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.91 to $85.43. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $86.73. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.98 to $87.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.02 to $88.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.04 to $89.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- The option is fully vested and exercisable.
- This option grant was previously reported as having an expiration date of September 11, 2023, which has been revised herein.
Billionaire Hedge Funds
